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In the central nervous system, a multilayered membrane layer known as the myelin sheath enwraps
axons, and is required for optimal saltatory signal conductance. The sheath develops from mem-
brane processes that extend from the plasma membrane of oligodendrocytes and displays a unique
lipid and protein composition. Myelin biogenesis is carefully regulated, and multiple transport path-
ways involving a variety of endosomal compartments are involved. Here we brieﬂy summarize how
the major myelin proteins proteolipid protein and myelin basic protein reach the sheath, and high-
light potential mechanisms involved, including the role of myelin speciﬁc lipids and cell polarity
related transport pathways.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The myelin sheath is a multilayered membrane system that is
produced by and extends from oligodendrocytes (OLG) in the cen-
tral nervous system. The sheath is highly enriched in lipids (ap-
prox. 70% of its dry weight), in particular cholesterol and the
glycosphingolipids galactosylceramide and its sulfated analogue
sulfatide [1]. In addition, several hundreds of proteins have been
detected, as revealed by gel-based proteome analysis [2]. However,
most prominently present are the two major proteins (approx. 80%
of the total protein fraction) myelin basic protein (MBP, 30%) and
proteolipid protein (PLP, 50%). Both proteins are instrumental in
the process of myelinating axons, i.e., the overall process that leads
to the wrapping of the myelin membrane around these neuronal
extensions, thus culminating in a multilayered organization, neces-
sary for rapid salutatory nerve impulse conduction. Perturbation of
the sheath (‘demyelination’) leads to several severe brain diseases,
including multiple sclerosis (MS).chemical Societies. Published by E
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.Before myelination is initiated, OLG precursor cells ﬁrst differ-
entiate into pre-myelinating oligodendrocytes and then into
myelin-producing cells. This transition is marked by the sequen-
tial appearance of myelin speciﬁc proteins, their localization
shifting during these differentiation stages from cell body to
plasma membrane extensions known as processes, which further
extend and develop into myelin sheaths. An intact cytoskeleton
is necessary for OLG process extension [3], while eventual com-
paction of myelin involves adhesion between cytosolic and
extracellular surfaces, mediated by MBP and PLP, respectively,
depolymerization of the cytoskeleton and subsequent elimina-
tion of cytosol.
One OLG can myelinate several axons, but since not all axons
are myelinated simultaneously, myelin biogenesis appears a highly
regulated event. The presence of axons, the natural target of the
myelin membrane and regulating actual myelination in vivo by
secreting axon-derived signals, is however not crucial as myelin
sheath biogenesis also occurs in vitro, i.e., in neuron-devoid OLG
cultures. In vitro, the myelin sheath is usually referred to as ‘myelin
sheet’, as wrapping only occurs in the presence of axons as in mixed
brain cultures. During active myelination in rat, it has been esti-
mated that the myelin-membrane surface area expands at a rate
of 5–50  103 lm2/cell/day, compared with a cell body surface
area (i.e., the plasma membrane) of approx. 300 lm2. Thus a strict
control of intracellular transport of myelin proteins and lipids to
each process is essential in the assembly and maintenance of
myelin.lsevier B.V. All rights reserved.
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the biogenesis of myelin sheaths/sheets with a particular focus
on molecular mechanisms underlying sorting and transport of
the major myelin proteins MBP and PLP, including the role of lipids,
axons and other ‘exogenous’ factors like the extracellular matrix
(ECM) in regulating these events. However, to properly appreciate
trafﬁcking pathways in OLG, it is particularly relevant to take into
account the polarized nature of these cells, containing two distinct
membrane surfaces, i.e., the plasma membrane surrounding the
cell body and the myelin membrane.
2. Oligodendrocytes express polarized membrane surface
domains
Although extending from the plasma membrane of the OLG cell
body, the myelin-membrane composition differs vastly from that
of the plasma membrane, emphasizing the polarized OLG pheno-
type. Furthermore, the myelin sheath itself is characterized by
compact and non-compact membrane regions that also differ in
(protein) composition. Obviously, this polarized nature sets partic-
ular requirements for a timely de novo biogenesis of myelin com-
ponents and their subsequent sorting and trafﬁcking to the sheath.
Indeed, several studies have drawn analogies between features of
and underlying mechanisms in the biogenesis and maintenance
of apical and basolateral membranes in polarized epithelial cells
on the one hand, and myelin sheath and cell body plasma mem-
brane on the other (summarized in [4]). In terms of molecular com-
position, like the enrichment of GPI-anchored proteins,
glycosphingolipids (in particular galactosylceramide (GalCer) and
sulfatide) and cholesterol, the myelin sheath resembles the apical
membrane domain, whereas the cell body plasma membrane
matches the basolateral surface [5,6]. However, quite intriguingly,
upon expression of the viral model proteins HA of inﬂuenza virus
and the G protein of vesicular stomatitis virus (VSV G) in cultured
OLG, HA localizes largely to the plasma membrane, whereas G VSV
G localizes to the myelin sheet [7]. Both these proteins are well-
established classical markers for vesicle-mediated protein trans-
port to apical (HA) and basolateral (VSV G) membrane surfacesFig. 1. Localization of syntaxin 3 (A–C) and syntaxin 4 (D–F) in mature oligodendrocytes
syntaxin 4 (D) and MBP (E). Merged image of A and B and D and E are shown in C and F
microscopy. Bar is 20 lm. Note that endogenous syntaxin 3 localizes to the cell body and p
4 primarily localizes to myelin-like membranes.in epithelial cells, involving the tSNARES syntaxins 3 and 4 as dock-
ing sites, respectively [8]. Quite unexpectedly, based on these cri-
teria for polarized transport, this would imply therefore that the
OLG plasma membrane is reached by an apical-like and the myelin
sheet by a basolateral-like mechanism. Interestingly, preliminary
work in our laboratory has revealed that in OLG syntaxin 3 is en-
riched at the plasma membrane while syntaxin 4 is predominantly
found in the myelin sheet, analogous to their enrichment at apical
and basolateral membranes in epithelial cells, respectively (Fig. 1).
Moreover, a tyrosine motif dictating basolateral sorting via its
association with the AP1B adaptor molecule [9] is also essential
for myelin-directed targeting. Tyrosine substitution directs VSV G
to the plasma membrane instead of the sheet, while insertion of
tyrosine in HA results in the opposite effect and causes HA to be
transported into the sheet [10]. Together these data suggest (for
a more detailed account see [4]) that a basolateral-like transport
mechanism dictates molecular translocation to the myelin mem-
brane, whereas plasma membrane directed trafﬁcking is mediated
by an apical membrane-like mechanism. However, like in hepato-
cytes, the major epithelial cell type in the liver, polarized transport
in OLG seems more complex than the presence of direct transport
pathways to myelin sheath and plasma membrane [11]. Thus like
in hepatocytes, also in OLG indirect transport pathways involving
transcytosis seem to operate, as revealed by the processing of
PLP (see below), following its biosynthesis at the endoplasmic
reticulum (ER). Moreover, although likely, a direct pathway of pro-
tein transport from trans-Golgi network to plasma membrane in
OLG has yet to be demonstrated.
3. Sorting and trafﬁcking of the major myelin proteins MBP and
PLP
The establishment of oligodendrocyte polarity, featured by the
appearance of two distinct membrane surfaces, i.e., the plasma
membrane and the multilayered myelin sheath/sheet, requires
sorting and targeting of membrane components to either surface,
and hence a tight regulation of the intracellular trafﬁcking machin-
ery. Moreover, myelin biogenesis is a rather complex event as. OLG were ﬁxed, permeabilized and co-stained for syntaxin 3 (A) and MBP (B), and
, respectively. Syntaxin localization was analyzed by confocal immunoﬂuorescence
rimary processes and not to myelin-like membranes, whereas endogenous syntaxin
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and often sorted and transported to myelin by different mecha-
nisms. For example, following its biosynthesis at the rough ER,
the myelin-speciﬁc protein PLP is initially sorted and transported
in transport vesicles to the plasma membrane, prior to reaching
the myelin sheath. In marked contrast, MBP is synthesised and in-
serted within the myelin membrane ‘on site’, involving microtu-
bule-dependent transport of MBP mRNA granules, rather than
the native protein, to the sheath. MBP is a basic, highly adhesive
peripheral myelin protein that faces the cytosolic membrane sur-
face, where it is involved in compaction of the myelin membranes,
while the major membrane-spanning central nervous system
(CNS) myelin protein PLP fulﬁlls a similar function by compacting
membranes at the exoplasmic side of the myelin that are apposed
to one another during the wrapping process (Fig. 2). It can thus be
readily rationalized why MBP and not PLP requires transport as its
mRNA, rather than that of the intact protein, as premature MBP-in-
duced membrane clustering in myelin biogenesis is precluded in
this manner. Furthermore, as both MBP and PLP stabilize apposed
myelin membranes in compact myelin, it is of particular impor-
tance that their transport and insertion to myelin membranes are
segregated and tightly regulated, both in time and space.
3.1. MBP: trafﬁcking, sorting and myelinogenesis
The MBP gene encodes two MBP families, classic MBP and golli-
proteins. Classic MBPs are exclusively expressed in myelin mem-
branes, and consist of different isoforms, mainly distinguished by
the inclusion or exclusion of exon 2. Strikingly, MBP is the only
myelin-speciﬁc protein known to be vital and indispensable for
myelin biogenesis [12]. Thus, MBP is not just an inert ‘glue’ that
mediates static interactions between intracellular leaﬂets of mem-
branes, but rather, is imperative in driving myelin assembly. The
different isoforms of MBP, which appear to localize to different
microdomains in the myelin membrane as reﬂected by a distinct,
isoform-dependent distribution in isolated detergent-resistant
microdomains (see also below and [13]) may reﬂect the multifunc-
tionality of this protein family in myelin maintenance. Indeed,
additional roles for MBP have been gradually recognized, including
roles in signaling, plasma membrane reorganisation and cytoskel-
etal interactions (see below and [12,14]).
To preclude MBP, given its strong adhesive properties, from
inappropriate and deleterious adhesive interactions with mem-
branes other than the cytoplasmic surface of the myelin mem-
brane, (exon 2 minus) MBP mRNA rather than MBP itself is
transported and targeted into OLG processes, thereby enabling pro-Fig. 2. Schematic illustration of the structure of the myelin sheath. Compact myelin is for
(forming the ‘double intraperiod line’), which will further facilitate MBP-mediated appos
dense line’). Adapted from [96].tein synthesis ‘on site’ [15]. In addition, the coupling of transla-
tional activity to mRNA localization not only prevents premature
ectopic expression of MBP, but also a rapid and selective insertion
of MBP into myelin membranes. In addition to MBP mRNA, several
other mRNAs, including those for MOPB, CAII and tau are also (co)-
transported to the myelin membranes, prior to expression of the
proteins [15,16]. However, intracellular trafﬁcking of mRNAs is
not exclusive to OLG, and has been demonstrated in a variety of
cells, particularly in the context of cell polarity establishment.
For example, in neurons a subset of mRNAs is localised to den-
drites, whereas others are targeted to axons [17].
Targeting of MBP mRNA via the processes to the myelin sheath
is a multistep process that involves nuclear export, assembly into
transport particles, trafﬁcking and anchoring to the target site,
and ﬁnally activation of translation. The ﬁrst step, i.e., nuclear ex-
port of MBP mRNAs is likely regulated by QKI RNA binding pro-
teins, which bind directly to the 30 untranslated region (UTR) of
MBP mRNA. OLG from quaking viable mice, an animal model for
demyelination, are unable to translocate MBP mRNA into the cyto-
plasm [18]. The underlying mechanism appears to rely on a failure
in switching from the expression of nuclear QKI-5 binding proteins,
which retain MBP mRNA in the nucleus, to QKI-6 and QKI-7 RNA
binding proteins, which facilitate nucleo-cytoplasmic shuttling.
In the cytoplasm, MBP mRNA assembles into ribonucleoprotein
complexes termed ‘granules’, representing translational transport
units that, besides RNA, contain the machinery for mRNA transla-
tion and protein synthesis [19]. This kind of assembly into granules
is not speciﬁc, as non-transported mRNAs display a similar aggre-
gation behaviour when microinjected into the cytoplasm [20].
However, speciﬁcity is conveyed at an earlier stage in the nucleus
when pre-mRNAs are selectively sorted upon association with a
subset of heterogeneous nuclear ribonucleoproteins (hnRNPs),
which determine the fate of the mRNA, i.e., its cytoplasmic loca-
tion, translation efﬁciency and mRNA turnover. This association in-
volves cis-acting location elements in the 30UTR of the mRNA,
which binds to a speciﬁc trans-acting factor involved in transport
and translational control. The 30UTR of MBP mRNA contains the
hnRNP A2 response element (A2RE), which is recognized by hnRNP
A2 and CBF-A, both of which mediate the intracellular trafﬁcking of
MBP mRNA to the myelin membrane [21,22]. mRNA localization
requires translational control, i.e., translational suppression during
transport until its arrival at the ﬁnal destination. In OLG, this is
accomplished through binding of the translational inhibitor hnRNP
E1 to hnRNP A2 [23]. Interestingly, MBP mRNA containing granules
lack Staufen [24], a well-characterized factor that generally partic-
ipates in mRNA transport and localization, as characterized inmed by the PLP-mediated apposition of the external leaﬂets of the bilayer membrane
ition of the internal leaﬂets and the extrusion of the cytoplasm (forming the ‘major
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tence of a different mRNA transport machinery in OLGs. The need
for an additional location element in the 30UTR, required to target
MBP mRNA to the ﬁnal designated location in the membrane, is
supportive of this suggestion [20].
The alternatively spliced isoforms of MBP are developmentally
regulated and targeted to different subcellular locations in OLG,
depending on the presence or absence of exon 2. These isoforms
differ in their coding sequence, but not in the untranslated regions
of their mRNAs. However, MBP mRNAs lacking exon 2 are trans-
ported into OLG processes, whereas exon 2 plus isoforms localize
to the nucleus and cell body cytoplasm [25,26]. What prevents
transport of exon 2 containing MBP isoforms is still obscure, but
it might be associated with the secondary structure of exon 2,
which could prevent or induce binding of a protein involved in
MBP mRNA transport. However, it is very likely that the activation
of the MBPmRNA transport machinery is regulated by other means
than the mere presence or absence of exon 2, as impaired isopre-
nylation also prevents transport of MBP mRNA [27]. Thus a role
for a developmentally expressed isoprenylated protein involved
in regulation of MBP mRNA could also be envisioned.
mRNA transport granules move to their site of destination along
microtubules in a kinesin-dependent manner [28] but their dock-
ing is still poorly understood. Thus, the actin cytoskeleton might
be important for anchoring and localizing mRNA, as observed in
other cells, but the identity of proteins involved in target recogni-
tion and docking is still largely obscure. It has been suggested that
the kinesin motor protein Kif1b, which is associated with a suscep-
tibility to MS, is speciﬁcally required for ectopic expression of mye-
lin by anchoring MBP mRNA to myelin membranes [29]. TOG
appears to be necessary for efﬁcient translation of MBP mRNA
[30] while at the target site Fyn activation triggers hnRNP A2 phos-
phorylation, causing the release of hnRNP E1, thereby allowing lo-
cal protein synthesis to occur [31].
An interesting issue is obviously the question as to whether the
mechanism of mRNA transport shares common features with the
mechanism of vesicular transport. In fact, prevailing evidence sug-
gests a closer resemblance in both events than previously thought.
Next to a role of microtubules in mediating both vesicular and
mRNA transport, as noted above, genetic screens in Drosophila re-
vealed that the ESCRT (Endosomal Sorting Complex Required for
Transport) complex, known to be involved in endosomal sorting,
is directly participating in the localization of bicoid mRNA [32].
Intriguingly, in zebraﬁsh it has been shown that the ATPase N-eth-
ylmaleimide sensitive factor (NSF), a cofactor in SNARE-mediated
membrane fusion, is essential for the organization of myelinated
axons, and for correct expression of MBP [33]. Similarly, although
a role in mRNA transport has not been examined yet, sec8, an exo-
cyst component and a central player in OLG vesicular transport, is
essential for MBP expression [34]. Also in yeast, a correlation be-
tween vesicle transport and the integrity of the actin cytoskeleton,
and subsequent mRNA transport and its localization to the growing
bud has been reported [35]. Finally, for the proper localization of
(oskar) mRNA in Drosophila a ‘tethering and anchoring’ role for
the small GTPase rab11, which trafﬁcs vesicles from recycling
endosomes to the plasma membrane, has been described [36].
However, it should be noted that the exact mechanism and the
quantitative contribution of recycling pathways in myelin sheath
biogenesis and maintenance are still largely unknown.
The use of similar molecular entities to direct trafﬁcking of
mRNA granules and membranous vesicles is surprising since
mRNA granules are protein–RNA complexes, and not membrane
bounded systems. Moreover, the estimated size of the MBP mRNA
granules is 600–800 nm [15], a diameter which is almost an order
of magnitude larger than commonly observed transport vesicles.
Of further interest in this regard, our unpublished ﬁndings suggestthat the SNARE machinery – instrumental in vesicular docking – is
also involved in MBP mRNA transport, emphasizing a causal rela-
tionship between the vesicular transport machinery and mRNA
transport in OLG. Monitoring MBP mRNA transport from the site
of initial granule assembly to its arrival and translation at its ulti-
mate destination as a function of manipulation of vesicular traf-
ﬁcking routes would be important to further clarify and deﬁne
the connection between vesicular and mRNA transport.
3.2. PLP trafﬁcking: vesicular transport in a polarized cell
PLP is an integral membrane protein, composed of 276 amino
acids and is predominantly expressed in OLG of the CNS. The PLP
gene is alternatively spliced during development to encode
DM20 and PLP. Both proteins consist of four transmembrane do-
mains with one intracellular loop and two extracellular ones. The
N- and C terminal are facing the cytoplasm (Fig. 2). DM20 differs
from PLP by a hydrophilic internal 35 amino acid segment deletion
in the intracellular loop. As a structural protein PLP plays a major
role in the correct apposition of the extracellular leaﬂets of the
membrane (double intraperiod line; Fig. 2), thereby stabilizing
the multilayered myelin membrane structure upon compaction.
Other functions of PLP have been suggested as well, including a
role in OLG survival and adhesion in relation to migration. Whereas
MBP is crucial for myelination to occur, PLP appears dispensable
and in its absence myelination of axons still occurs, albeit that in
PLP null mice myelin stability diminishes as a function of time [37].
PLP is synthesized in the ER and subsequently transported via
vesicles to the Golgi, followed by transport to the myelin sheath.
The underlying sorting machinery as to how PLP reaches its ﬁnal
destination is unclear, but insight of the overall transport pathway
is gradually emerging and suggests indirect transport of PLP to the
sheath, i.e., via the plasma membrane of the cell body rather than
its direct transport from the Golgi to the sheath. Palmitoylation at
three cysteine residues in the N-terminal region of PLP is required
for myelin-membrane localization [38], but other sorting determi-
nants are likely playing a role as well. Indeed, DM20 seems to assist
the trafﬁcking of PLP [39], and a role for both GalCer and sulfatide
in PLP transport has been suggested, although the exact role of
these lipids in PLP transport is still a matter of controversy. In iso-
lated brain slices transport of PLP into myelin was reduced by ap-
prox. 50% upon inhibition of overall glycosphingolipid synthesis,
whereas neither the insertion of MBP nor protein synthesis as such
were affected. In addition, a correlation between PLP and sulfatide
was suggested based on vesicular co-transport in brains of 20 day
old rats [40]. Furthermore, PLP association with cholesterol and
GalCer-enriched membrane domains during biosynthetic transport
in cultured oligodendrocytes appears critical [41] (see below). In
contrast, other studies demonstrated that the sorting and trafﬁck-
ing of PLP to the processes and myelin sheet is not affected upon
inhibition of sulfatide synthesis [42], while PLP is transported to
the plasma membrane in GalCer- and sulfatide deﬁcient CHO cells
[5]. These latter observations are in line with in vivo data, showing
that in mice, unable to synthesize GalCer and/or sulfatide, trans-
port of PLP to myelin sheaths was uninterrupted [43]. These appar-
ent contradictory ﬁndings may originate from the different
experimental conditions. In this regard it should be particularly ta-
ken into account that multiple pathways seem to operate in overall
PLP transport, implying that distinct stages could involve distinct
transport vehicles involving potential localization of PLP in differ-
ent microdomains in a transient manner. In the context of the
polarized nature of the OLG, it is of interest that early after biosyn-
thesis, PLP localizes at the surface of OLG in similar domains as the
apical viral model protein, HA, i.e., the cell body plasma membrane
[41]. This could suggest that like in polarized epithelial cells, PLP
might reach the myelin sheet via an indirect, i.e., transcytotic
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Oli-neu cells, an in vitro cell model for OLG, PLP, rather than by di-
rect transport from Golgi to myelin membranes, is ﬁrst transported
to the cell body plasma membrane. In the absence of neuronal sig-
nals, PLP is subsequently internalized by a clathrin-independent
but cholesterol-dependent mechanism and stored into late endo-
some (LE)/lysosomal compartments [44]. Neuronal signals cause
the release of PLP from these compartments and its return to the
plasma membrane, which is presumably instrumental in subse-
quent transport of PLP to the sheath, thus promoting myelin bio-
genesis and stability. Quite intriguingly, in the same Oli-neu cell
line and the human oligodendroglioma derived cell line HOG, a
MAL-2 containing compartment has been identiﬁed which might
be reminiscent of the apical recycling endosome (ARE) or subapical
compartment (SAC) [45]. This compartment is also localized in epi-
thelial cells, including liver cells, where it acts as a sorting and traf-
ﬁcking center in transcytotic transport, in which MAL2 functions as
an essential transport regulator (see [11]). It will therefore be of
great interest to investigate the exact involvement of this compart-
ment in OLG as well, including its (functional) relationship with
the endosomal/lysosomal storage compartment, if any.
In line with this polarity-based transport mechanism of PLP are
further observations that when stably expressed in polarized Ma-
din–Darby canine kidney (MDCK) cells, PLP is transported to the
apical (mechanistically reminiscent of the plasma membrane in
OLG) rather the basolateral domain (reminiscent of the myelin
sheet) [46]. Similarly, upon transient expression in polarized
HepG2 cells, PLP is localised exclusively at the apical membrane.
However, quite intriguingly, when stably expressed in HepG2 cells,
localization of PLP at the apical (bile canalicular) membrane is fol-
lowed by transcytosis to the basolateral membranes (our unpub-
lished observations). Interestingly, although extrapolation of
ﬁndings obtained in different cell types should be done but with
great caution, it is very tempting to emphasize here that in mature
OLG PLP reaches its ﬁnal destination via an indirect, transcytotic
pathway, very reminiscent of that seen for many apical resident
proteins in hepatocytes, traveling via the basolateral surface [11].
Moreover, in both HepG2 and MDCK cells, (ﬂuorescently-tagged)
GalCer but not GlcCer is speciﬁcally transported to the basolateral
membrane [47], paralleling mechanistic features of the myelin
membrane in OLG [12].
Thus far knowledge concerning docking and ﬁnal insertion of
PLP into the sheath/sheet is scanty. A variety of syntaxins have
been detected in OLG [6,48], our unpublished observations], but
their localization, let alone their involvement in docking of trans-
port vesicles, is largely unknown. Our preliminary data suggest a
role of syntaxin 3 in PLP transport, most likely in plasma mem-
brane docking after transport from the Golgi, following de novo
biosynthesis. Quite interestingly, OLG express SNAP-29 during
myelination [48,49] and this tSNARE contains in its N-terminal re-
gion a binding domain for rab3A. Moreover, overexpression of PLP
and rab3A in HEK293 cells promoted surface directed trafﬁcking of
PLP, thus suggesting that rab3A may be involved in membrane fu-
sion of PLP-containing transport vesicles, docking at SNAP-29 tar-
get sites. It will be of particular interest to reveal in OLG whether
and in which complex transport step the rab3/SNAP-29 machinery
is operating.
The dynamic integration of PLP into distinct membrane do-
mains in a time dependent manner, following its biosynthesis
and ensuing transport to the sheet, is reﬂected by its detergent-sol-
ubility behaviour, usually applied as a criterion for localization in a
distinct membrane microdomain [1]. Thus, after biosynthesis PLP
acquires signiﬁcant 3-[3-chloramidopropyl)-dimethylammonio]-
1-propane-sulfonate (CHAPS) detergent resistance only after 30–
60 min, i.e., the time likely required for PLP-containing transport
vesicles to reach the plasma membrane and subsequently LE/lyso-somal compartments [41]. PLP’s redistribution from a CHAPS-solu-
ble to a CHAPS-insoluble domain presumably reﬂects a sorting
step, but where this transition takes place is an important, but as
yet unresolved issue. Viral infection based pulse chase experiments
suggest that PLP is largely CHAPS-soluble in the Golgi and at the
plasma membrane, and that PLP becomes CHAPS-insoluble upon
its accumulation with cholesterol in LE/lysosomal compartments
[50]. Of interest in this context is the observation that rsh PLP, a
natural mutation occurring in mice, fails to sequester to CHAPS-
insoluble domains due to an impaired cholesterol binding [51].
However, rsh PLP traverses the Golgi to the cell surface and then
enters the endocytic pathway for transport to LE/lysosomal com-
partments, but does not reach myelin membranes. Together, these
ﬁndings support the view that PLP’s localization in a cholesterol-
enriched microdomain is crucial for ﬁnal transport to the myelin
sheet, but is not required for transport through the Golgi and to
the plasma membrane. Whether the cholesterol dependence of
PLP’s internalization (possibly in conjunction with the presence
of sulfatide, see below) at the plasma membrane relates to the
need of PLP’s localization into such a cholesterol-enriched domain
for internalization or is merely a matter of cholesterol-dependent
invagination per se, merits further investigation. Another intrigu-
ing matter is how PLP-mediated adhesion of opposing membranes
in the ER is prevented. Conformational changes forced upon PLP by
its segregation into different lipid environments along its trafﬁck-
ing route, is an appealing option. Recently, we have extensively
discussed the evidence and structure–function relationship of rafts
in OLG [1]. Here some comments are warranted as to the role of
GalCer and sulfatide in myelin biogenesis.4. Membrane microdomains in OLG: role of GalCer, sulfatide
and cholesterol
It is now widely accepted that membranes contain heterogene-
ities, implying that different domains of different composition and
physical properties may coexist within the lateral plane of the bi-
layer. Indeed, like from virtually every cell type, also from OLG
membrane fractions can be isolated, that are resistant toward
extraction with or soluble in non-ionic detergents, ﬁndings that
are interpreted of reﬂecting the presence of liquid-ordered mem-
brane microdomains, also know as ‘rafts’, and ﬂuid liquid domains,
respectively. These ﬁndings are consistent with the abundant pres-
ence of galactolipids and cholesterol in the myelin sheath, com-
prising approx. 90% of the outer leaﬂet of the myelin membrane
[5] and lipid-modiﬁed myelin proteins [by fatty acylation (PLP)
or GPI anchoring (NCAM120, contactin)] that display a preference
of interacting with such domains. Moreover, it has been well-
established that interference with cholesterol synthesis results in
defects of myelination [52] and that the potential beneﬁcial thera-
peutic use of statins to suppress inﬂammation in demyelinating
diseases is highly frustrated by its ability to inhibit at the same
time squalene synthase, a crucial intermediate step in cholesterol
biosynthesis. Interestingly, for myelination in the peripheral ner-
vous system (PNS) it has been reported that neurons exploit a cho-
lesterol homeostatic mechanism that forces Schwann cells to
produce newmembranes for the myelin sheath [53]. This is accom-
plished by neuronal secretion of neuregulin and subsequent activa-
tion of neuregulin receptors, which eventually increases the
transcription of 3-hydroxy-3-methylglutarylcoenzyme A reduc-
tase, the rate-limiting enzyme for cholesterol biosynthesis. Also a
strong phylogenetic correlation between myelination and choles-
terol biosynthesis was revealed. Moreover, to further emphasize
the essential role of cholesterol in myelin biogenesis, quantitative
analysis of the cholesterol pool in white matter of control and
MS patients revealed that cholesterol is depleted in white matter
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these notions further emphasize the importance of maintaining a
proper pool of membrane cholesterol and its critical role in myelin
biogenesis, in all likelihood particularly related to the assembly of
membrane microdomains. Given the involvement of such domains
in sorting and trafﬁcking as well as distinct functional aspects, like
intercellular interactions and signaling, the role of these microdo-
mains in OLG functioning are warranted and recent reviews have
focused on several of these aspects [1,4,55]
Although lipids, as an inherent part of the membranes of trans-
port vesicles, can be moved in this manner to their sites of destina-
tion, non-vesicle-mediated transport pathways, involving lipid-
speciﬁc transport proteins have also been reported, as observed
for a variety of lipids, including ceramide [56], glucosylceramide
[57], and cholesterol [58]. Current evidence supports predominant
vesicle-mediated transport of the major glycosphingolipids GalCer
and its sulfated analogue, sulfatide, to the sheath, following bio-
synthesis of GalCer at the ER lumen, and sulfation of part of this
fraction in the Golgi. However, a signiﬁcant fraction of GalCer
may circumvent the Golgi, and has been suggested to be directly
targeted, together with cholesterol, from the ER to endosomal
compartments and/or myelin membranes in sigma-1 receptor po-
sitive lipid droplets [59]. Interestingly, whatever their mechanism
of transport, both lipids do not colocalize in the sheath, but rather
are distributed to distinct domains, thereby presumably reﬂecting
differences in their sorting and trafﬁcking (i.e., localization in dis-
tinct membrane domains and perhaps transport vesicles) and,
likely, their function. Thus, in vivo, GalCer is found in compact
myelin, where PLP localizes, whereas sulfatide localizes to non-
compact myelin [4]. In cultured OLG sulfatide is strongly enriched
in the cell body plasmamembrane and primary and secondary pro-
cesses, but is largely excluded from the sheet, where GalCer pri-
marily localizes [4]. Thus, whereas the association of PLP with
GalCer and cholesterol in LE/lysosomal compartments appears to
be a crucial step in trafﬁcking of PLP to the sheet, a role for sulfa-
tide is less clear. Our recent data suggest that PLP and sulfatide are
not co-transported to the plasma membrane, but rather that sulfa-
tide has a regulatory role in the cholesterol-dependent and clath-
rin-independent internalization of PLP, and its association to
CHAPS-resistant membrane microdomains. Therefore, distinct
roles of GalCer and sulfatide at different stages in trafﬁcking can
be envisioned. Indeed, in mice that lack GalCer and sulfatide, PLP
is CHAPS soluble, and fails to segregate to CHAPS-resistant do-
mains [41]. However, in these mice PLP trafﬁcking is apparently
not timely regulated and trafﬁcs to the myelin membranes by bulk
ﬂow or an unknown compensatory mechanism that allows CHAPS-
soluble PLP to insert into myelin membranes. Indeed, downregula-
tion of the genes for ceramide galactosyl transferase and cerebro-
side sulfotransferase, key enzymes in the synthesis of GalCer and
sulfatide, respectively, does not dramatically perturb overall mye-
lin structure [43,60], but rather appears restricted to perturbations
of the formation and maintenance of the paranodal structure, pos-
sibly related to aberrant trafﬁcking of neurofascin 155 (NF-155)
and contactin-associated proteins (Caspr-1 and 2) [85], and/or
their exclusion from detergent-resistant microdomains, which
seems of high relevance for the trafﬁcking and localization of NF-
155 at the paranodal loop [61]. Indeed, occasionally the myelin
wraps lose contact at the extracellular leaﬂets of the membranes,
which may well be related to the observation that impaired syn-
thesis of galactosphingolipids inhibits efﬁcient trafﬁcking of PLP
to the myelin sheath, as noted in the previous section, but does
not eliminate it.
Sulfatide localizes particularly in the plasma membrane of ma-
ture OLG, where its preferential internalization over other simple
glycosphingolipids by endocytosis has been reported [62]. Here,
it may also play a role in the sorting of PLP and its internalizationvia a raft-mediated non-clathrin-mediated endocytic pathway [44]
as part of a speciﬁc transcytotic pathway to the sheet membrane,
after having reached the plasmamembrane following biosynthesis.
Importantly, compact and non-compact myelin may thus be
reached by distinct transport pathways as reﬂected by differences
in the distribution of compact and non-compact membrane pro-
teins. Indeed, proteins localizing in these different domains have
been noted to follow distinct endocytic and recycling pathways
[63].
Studies of protein–lipid and protein–membrane interactions
carried out in lipid monolayer systems have revealed that mem-
brane proteins may act as fundamental structuring factors, driving
lateral heterogeneity. Thus proteins are known to mediate the for-
mation of domains through electrostatic and hydrophobic lipid–
protein interactions [64], and exclusion or partitioning into choles-
terol-enriched phases [65]. Both PLP and MBP constitute major
structuring factors in that their integration in or adsorption to
the myelin membrane leads to a local lateral reorganization of
the lipid molecules, forming microdomains around the proteins
and accounting for the myelin-membrane’s surface topography,
including membrane rafts [66]. Other proteins could act in concert
with the formation of these domains and thereby provide the plat-
forms for intracellular sorting and trafﬁcking (PLP) to their site of
destination and/or functioning otherwise, i.e., in stabilizing the
sheath (MBP and PLP), among others via reduction of electrostatic
dipolar repulsion of the lipids and strengthening of Coulomb inter-
action [66]. Seemingly subtle structural differences within a mye-
lin protein, based upon the presence of distinct isoforms of some of
them, provide an additional parameter for driving a protein’s dis-
tinct distribution in raft and non-raft fractions. This is observed
for MBP, showing that phosphorylated MBP rather than non-phos-
phorylated MBP is localized in rafts [67]. It has been similarly sug-
gested that structural differences of the protein on the level of the
carbohydrate groups could be important factors in the protein’s
lateral membrane distribution in myelin [68], and possibly thereby
their ability of organizing different microdomains and/or targeting,
which may include, for example, lectin-like molecules. Thus differ-
ent structural isoforms of the proteins may exist which in this
manner might thus dictate their distinct lateral membrane locali-
zation, which in turn determines the protein’s fate, in terms of
recruitment in distinct vesicles and ensuing transport. In this con-
text, it has been shown that in the PLP gene mutant shp (shaking
pup) the mutated PLP selectively accumulates in the rough ER,
i.e., its trafﬁcking is perturbed [69], as has been reported to occur
for many other mutations in PLP [51,70]. The shp mutation in-
volves a substitution of the conserved amino acid His by Pro (an al-
pha helix breaker) in the ﬁrst extracellular loop (Fig. 2). Also in this
case structural aberrations, which are not directly related to the
transmembrane domains, presumably underlie the failure of the
protein to be recruited for exiting from the ER and its transport
to the Golgi for subsequent posttranslational modiﬁcations. Simul-
taneously, the presence of other major proteins (including MBP) in
shp myelin was reduced, causing severe myelin deﬁciency and sug-
gesting the coordinated regulation of overall myelin protein
recruitment. Part of this diminishment was due to enhanced apop-
tosis of OLG, but the extent to which de novo synthesis or transport
efﬁciency were affected, remains to be resolved. The intriguing
possibility may exist that by recruiting distinct lipid environments,
integration of other proteins in such distinct domains may be facil-
itated as well. Such a co-dependence in transport of a distinct pro-
tein has been shown [2] in a PLPnull mutant where a virtual
absence in the sheath of sirtuin 2 (SIRT2), a nicotinamide adenine
dinucleotide (NAD+)-dependent protein deacetylase of unknown
function, was noted as well. This could suggest that PLP/DM20 is
required for the transport of distinct proteins into the myelin com-
partment, possibly involving a mechanism that by interacting with
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certain proteins in such domains followed by their co-transport to
the sheath. Also DM20 seems to assist in the trafﬁcking of PLP
[52,53].
In this context it is ﬁnally relevant to note that in model mem-
branes, sulfatide readily engages in domain formation with other
sphingolipids, including GalCer, and mixes with cholesterol in
phosphatidylcholine bilayers where liquid-ordered and liquid-dis-
ordered phases coexist [71]. Interestingly however, depending on
its fatty acid composition, sulfatide (like other glycolipids) may
associate with cholesterol to a different extent [72], thereby likely
affecting the physicochemical properties of the microdomain and
hence its cargo.
Apart from their role in the lateral organization of the mem-
brane, transmembrane interactions between GalCer and sulfatide,
i.e., between apposed membranes, may also occur and contribute
to myelin biogenesis and stability. It has thus been proposed (for
review see [73]) that upon wrapping around the axon, the lipids
in apposed membranes might interact and initiate GalCer/sulfa-
tide-enriched microdomains that are thought to participate in
trans carbohydrate–carbohydrate interactions, acting across ap-
posed OLG membranes, when they face each other in the multilay-
ered myelin sheath. This event subsequently triggers
transmembrane signaling that leads to a depolymerization of the
cytoskeleton and clustering of membrane constituents. This may
result in squeezing out the cytosol and promote increased adhe-
sion of the apposed surfaces, thereby producing and stabilizing
compact myelin. Thus, it has been suggested [73] that in this
way, i.e., in a transient manner as a result of membrane undulation,
a so-called ‘glycosynapse’ can be formed, which might be instru-
mental in myelin–axon communication.5. Myelin biogenesis: exogenous regulation
Although in vitro OLG produce myelin-like membranes in the
absence of axons, in vivo myelin is only produced upon axonal ‘re-
quest’. Thus, axonal cues, either adhesive or secreted, inﬂuence
OLG development, which includes initiation and regulation of sort-
ing and trafﬁcking of myelin-speciﬁc proteins and lipids. Astro-
cyte-mediated signals also contribute to myelination, but likely
not in the early phase of this process.
It is well documented that OLG in culture develop a polarized
phenotype when grown on a ‘non-speciﬁc’ adhesive substrate
and in the presence of an overwhelming cue of signals, such as
growth factors, present in the culture medium. However, in vivo
the situation is obviously more complex. During CNS development,
each OLG process is in contact with a distinct temporally and spa-
tially changing environment. Thus myelin formation is initiated
when the axonal membrane and that of the OLG process meet,
i.e., actual myelination commences when several processes inter-
act with axons, rather than as a result of a single process–axon
interaction [74].5.1. Adhesive interactions
Several cell–cell and cell–ECM adhesions contribute to induc-
tion and maintenance of myelin. Other parameters, triggering
and/or facilitating the onset of myelination include the axonal
diameter, and developmentally regulated axonal signals. Indeed,
a plethora of signals and molecular interactions seem to drive
the early onset of myelination, but how these various processes
are orchestrated is still largely unknown. Among others, the initia-
tion of myelination relies on contacts at the paranodal regions and
signals involving a trans-mode type of interaction between OLG
NF-155 and axonal Caspr [75], which may mutually affect theirrecruitment and distribution at the contact side, presumably local-
izing to speciﬁc membrane domains, acting as interaction plat-
forms. Other key players in the initial interaction events in CNS
myelination seem to include the cell-adhesion molecule Nectin-
like 1 which is exclusively expressed by neurons in the CNS, its dis-
ruption resulting in a developmental delay of myelination [76].
Furthermore, also the developmentally upregulated axonal adhe-
sive protein L1, and the ECM protein laminin-2 [77], have been
implicated in the initiation of myelination. Interestingly, other ax-
onal proteins such as PSA-NCAM and LINGO-1 that are develop-
mentally downregulated may delay the rate of myelination
[78,79], thus reﬂecting the tight balance of regulation of myelina-
tion by axonal protein expression per se.
ECM molecules and their major receptors, integrins, are in-
volved in governing and orienting apical–basal polarity in a variety
of cells. The onset of polarity development in epithelial cells re-
quires basal ECM attachment, a situation which might also be valid
in OLG polarity development. OLG, cultured on laminin-2, show
speciﬁc myelin sheet-directed vesicular trafﬁc of the viral basolat-
eral model protein VSV G [80] while formation of myelin sheets is
promoted, relative to the sheet formation of cells grown on the in-
ert substratum poly-L-lysine. Given its expression in developing
axonal tracts [77], and the observed myelination defects in mice
and humans upon its deﬁciency, laminin-2 is an ideal candidate
as a spatial cue to orient OLG polarization, i.e., by facilitating baso-
lateral-directed trafﬁcking to myelin membranes, thereby initiat-
ing myelination. Interestingly, when OLG are grown on
ﬁbronectin, another ECM molecule that is abundantly expressed
in MS lesions, myelin sheet-directed vesicular trafﬁc of VSV G
and PLP is signiﬁcantly impaired [80], coinciding with a frustrated
polarity development of the cells. Interestingly, MBP is expressed
in OLG grown on ﬁbronectin, and although myelin formation is
strongly reduced, some cells were able to produce myelin sheets.
These myelin sheets contain MBP, but lack PLP and VSV G, suggest-
ing that transport of MBP-containing mRNA granules and its trans-
lation is less strictly ECM-dependent than sheet-directed vesicular
trafﬁcking, which is required for PLP delivery into the sheet.
At the molecular level, laminin-2 interferes with the lateral dis-
tribution of integrins, allowing integration of integrin and growth
factor signaling to direct OLG behaviour, in particular survival
and myelination [81]. Integrins, a family of heterodimeric trans-
membrane receptors, are often critical mediators of cellular inter-
actions with ECM. Of the 20 known integrin species, OLG express a
limited repertoire, i.e., avb1, avb3, avb5, avb8, and a6b1, and the
expression of each integrin receptor is speciﬁcally associated with
one aspect of OLG behaviour. b1 integrin has been implicated in
target-dependent myelination, although seemingly different and
conﬂicting results have been published upon loss of function of
b1 integrin concerning its role in oligodendrocyte survival and/or
myelination [82–84]. This might be due to the timing of b1 integrin
deﬁciency, i.e., whether it occurs at the progenitor, premyelinating
or myelinating stage of OLG development. Furthermore, a loss of b1
integrin in OLG can be compensated for by dystroglycan, a laminin
receptor present in OLG [85], that organizes cellular polarity in epi-
thelial cells. Nevertheless, since myelin defects, both in vitro and
in vivo are observed upon loss of (a6)b1 integrin function in
OLG, a poor polarization of the cells upon b1 integrin deﬁciency
could be the underlying mechanism.
Intracellular integrin signaling is often mediated by small GTP-
ases, such as Rac, Rho and Cdc42. Cd42 and Rac1 play a critical role
during the early stages of myelination, particularly in compaction
[86]. Mutant mice show thinner myelin sheaths, but the periodicity
of compact myelin and the expression of myelin proteins, includ-
ing MBP and PLP, is not affected. In addition, large vesicles are
sometimes found in the excess cytoplasm, suggesting a role of
these small GTPases in vesicular transport and/or OLG polarity
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endocytosis of PLP, enhances MBP expression, and condenses the
plasma membrane in a polarized manner [87]. An unknown factor,
secreted by neurons, downregulates Rho activity, and thereby
transcytosis of PLP, whereas the effect on MBP expression is likely
mediated by adhesive axo-glia interactions. Indeed, axonal LINGO-
1 prevents myelination as it decreases fyn kinase activity in OLG,
resulting in enhanced Rho activity, with a subsequent decrease in
MBP expression [88], possibly related to diminished transport of
MBP mRNA granules into the sheet. In contrast, tenascin-R medi-
ated inhibition of Rho activity prevents myelin-membrane forma-
tion without altering the number of MBP-expressing cells [89].
Tenascin-R is an ECM molecule, mainly expressed by OLG, which
acts as an autocrine factor and binds to OLG via a sulfatide-medi-
ated mechanism. It is tempting to suggest that tenascin-R may
‘shield’ sulfatide in this manner and thereby preclude sequestra-
tion of the lipid into correct membrane microdomains.
Alternatively, tenascin-R might modulate Rho activity via a fyn-
independent pathway allowing OLG differentiation without imme-
diate myelin formation.
Fyn, a member of the src kinase family, appears to play a central
role in OLG differentiation and initial events of myelination. Mice
that lack fyn display a myelin deﬁcient phenotype, showing re-
duced amounts of MBP [90]. As discussed above, the underlying
mechanism likely involves fyn-mediated translation of MBP mRNA
via phosphorylation of hnRNP A2. Axonal L1 binding to oligoden-
droglial contactin (F3) appears to be the trigger for fyn activation
and subsequent targeted MBP translation [30]. Fyn is however also
one of the components of the intracellular signaling pathway of
integrins, acting upstream of Rho, Cdc42 and Rac. Assembly of a
lateral integrin/contactin complex, which may also include NCAM
120 has been implicated in the differential control of fyn activity
[91], mediating OLG survival and myelination, and co-amplifying
cell–cell and cell–ECM adhesion. In passing, all these components
are known to concentrate in rafts, and their clustering in this man-
ner would thus provide an optimal environment for sequential and
timely activation of molecular players in the overall process. In
fact, such coordinated adhesion, might be an elegant way to syn-
chronise trafﬁcking of the major myelin components MBP and
PLP, as further discussed below.
5.2. Soluble factors
Similar to adhesive interactions, secreted soluble factors could
also inﬂuence sorting and trafﬁcking of myelin proteins. As already
referred to above, a diffusible neuronal signal may inhibit Rho
activity and thereby clathrin-independent endocytosis of PLP
[87]. In addition, a neuronal cAMP-dependent signaling pathway
triggers PLP exocytosis from late endosomal storage compartments
to myelin-like membranes [44]. However, the identity of the se-
creted neuronal signal(s) remains to be determined.
Protein kinase C (PKC) activation prevents OLG differentiation
via differential control of cognate polarized trafﬁcking pathways
at the onset of myelination [92]. Upon PKC activation, both OLG
progenitors and mature cells are no longer capable of regulating
actin-membrane interactions [80,92]. As a result of PKC-mediated
phosphorylation of MARCKS, actin ﬁlaments redistribute to the
submembranous or cortical actin cytoskeleton, which impedes
plasma membrane directed trafﬁc of ‘basolaterally’ sorted VSV G
[80,92]. Consistent with data obtained for this viral model protein
as a marker of sheet-directed transport, PKC activation also inhibits
PLP transport to myelin-like membranes, but not the appearance of
MBP [10], emphasizing the speciﬁcity of this effect on vesicular
trafﬁcking, possibly on docking, given the dependence of both
MBP mRNA granules and PLP transport vesicles on ﬁlament integ-
rity. FGF-2, which is secreted by neurons and astrocytes, shows asimilar PKC-dependent actin redistribution in OLG progenitors
[93], suggesting that FGF-mediated inhibition of OLG differentia-
tion might be due to impaired polarity development.6. Myelin biogenesis: the myelin synapse
Taken together, the evidence obtained thus far is consistent
with the notion that MBP and PLP trafﬁcking are physically segre-
gated to limit ectopic assembly and compaction of myelin mem-
branes around axons. Regulation of their trafﬁcking is under
neuronal control, and in addition, tightly linked and coordinated.
The fact that MBP trafﬁcking is mainly regulated by adhesive inter-
actions, and PLP by secreted factors is very intriguing and lead us to
suggest the following model for myelin-membrane formation
(Fig. 3).
Upon differentiation OLG extend multiple (primary) processes,
which branch into secondary and tertiary ones, in search of mye-
lin receptive axons. Upon axonal recognition, secondary and ter-
tiary processes disappear, and axonal L1 and laminin-2 engage
their ligands, i.e., oligodendroglial contactin for L1 and integrin
a6b1 and/or dystroglycan for laminin-2 (Fig. 3, 1). Likely, these
receptor–ligand pairs become spatially organized into a distinct
stable signaling entity, e.g. a raft-like structure. The L1–contactin
as well as the laminin-2–integrin interaction will differentially
control fyn kinase activity, which will induce MBP translation
(Fig. 3, 2), orient OLG polarity (Fig. 3, 3a) and initiate myelin-
membrane biogenesis (Fig. 3, 3b). These interactions across the
apposed membranes very much resemble the interface between
an antigen presenting cell and a T-cell, i.e., the immunological
synapse, and in the case of myelination can therefore analo-
gously be referred to as a ‘myelin synapse’. MBP expression
mediates lateral raft clustering, plasma membrane condensation,
and cytoskeleton disassembly, thereby narrowing intermembrane
distances that enables in concert with the action of (extracellu-
lar) PLP multilamellar myelin-membrane growth and stabiliza-
tion around an axon. In addition, MBP binds to the SH3
domain of fyn [94], and might regulate its activity. At the same
time, when OLG polarity development further matures in the
presence of laminin, de novo synthesis of PLP will be promoted
and stored PLP will be recruited from LE/lysosomal storage com-
partments for myelin biogenesis and ensuing myelination (Fig. 3,
3a and 4). To this end we suggest that neurons will trigger the
secretion of a soluble cAMP-dependent factor, via an as yet un-
known mechanism (Fig. 3, 5), which will trigger co-transport of
PLP/GalCer/cholesterol from the storage sites via a direct or indi-
rect (e.g. via ARE/SAC) transport pathway to the myelin mem-
branes (Fig. 3, 6). The subsequent integration of PLP into
myelin membranes will allow close apposition of the extracellu-
lar leaﬂets of different wraps, thereby providing a possibility of
trans-carbohydrate–carbohydrate interactions between GalCer/
sulfatide, exposed on extracellular leaﬂets, across opposing
membranes, as discussed above. The formation of these ‘glyco-
synapses’ may then trigger a redistribution of MBP in the intra-
cellular leaﬂet, enabling its association with PLP and
reorganisation (depolymerisation) of actin ﬁlaments and micro-
tubules [14], events that are imperative for compaction to occur
(Fig. 3, schematic step 7).
Obviously, to test this model, further studies at a multidisciplin-
ary level, from biophysics to cell biology, involving model mono-
layer studies, in vitro cell cultures and animal studies, are
warranted to fully understand the overall process of myelin bio-
genesis, myelin wrapping and compaction, including myelin stabil-
ity. However, the myelin synapse model does accommodate that
MBP initiates the onset of myelination and is therefore indispens-
able for myelination, whereas PLP is not. This is also reﬂected by
Fig. 3. Schematic illustration of the ‘myelin synapse’. Two distinct adhesive signals – L1–contactin and laminin-integrin a61 – between the axon and a primary process of
oligodendrocytes will form a complex (‘myelin synapse’, 1) that will initiate a cascade of reactions ultimately leading to an insulating myelin sheath: synthesis of the myelin-
speciﬁc proteins MBP (2) and PLP (3b, 4), myelin-membrane extension and axonal enwrapment (3a), transcytotic PLP transport via a direct of indirect pathway (6), directed
by a diffusible axonal signaling factor (5), and ﬁnally myelin compaction (7, see Fig. 2). See text for further details.
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Shiverer mice, which bear a mutation of MBP, are myelin deﬁcient,
and have reduced amounts of PLP. Indeed, it has been reported that
PLP expression is initiated upon correct axonal adhesion. This
MBP-mediated secondary reduction of PLP is actually very often
observed. In addition, in rat-derived myelinating mixed brain cell
cultures, MBP appears in myelin membranes prior to GalCer and
PLP (our unpublished observations). Furthermore, structurally al-
tered PLP or its overexpression leads to premature death of OLG
at the end of the myelination period [95], indicating that myelin-
membrane expansion and wrapping is not dependent on PLP.
The model implies that the neuron senses when myelin forma-
tion succeeds and it will be important to identify molecular players
involved in this process, for example like neuregulin in Schwann
cell myelination in the PNS, as described above. By a direct link be-
tween signaling and trafﬁcking, such an axon-coordinated, sequen-
tial recruitment of MBP and PLP to myelin is warranted, thereby
preventing premature and inefﬁcient myelin compaction.
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